GlassScriptPhysician profile
Richard Feldman
NPI 1134102239
$475,790.99
in general payments reported to CMS, 2019-2025
15 companies · $87.69 in 2025
The $87.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $5,304 · 2021: $59K · 2022: $138K · 2023: $132K · 2024: $118K · 2025: $87.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $187K · Travel and Lodging: $57K · Food and Beverage: $5,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $187,150.00 |
| Travel and Lodging | $57,365.55 |
| Food and Beverage | $5,970.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $440,401.65 | 2019-2025 | Shingrix, Arexvy |
| Sanofi Pasteur INC. | $33,539.16 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $1,288.66 | 2021 | |
| Abbvie INC. | $204.95 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $92.42 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.70 | 2019-2020 | |
| Pfizer INC. | $42.74 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.54 | 2019-2021 | |
| Cranial Technologies, INC | $24.58 | 2025 | Doc Band |
| Gilead Sciences, INC. | $24.21 | 2021 | |
| Novo Nordisk INC | $20.84 | 2023 | Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $20.39 | 2022 | |
| Dynavax Technologies Corporation | $16.05 | 2025 | Heplisav-B |
| Astellas Pharma US INC | $13.55 | 2019 | |
| Exact Sciences Corporation | $13.55 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.